As of 2026-07-17, the Intrinsic Value of ADENTRA Inc (ADEN.TO) is 161.60 CAD. This ADEN.TO valuation is based on the model Discounted Cash Flows (Growth Exit 5Y). With the current market price of 37.34 CAD, the upside of ADENTRA Inc is 332.80%.
The range of the Intrinsic Value is 111.32 - 271.68 CAD
Based on its market price of 37.34 CAD and our intrinsic valuation, ADENTRA Inc (ADEN.TO) is undervalued by 332.80%.
| Range | Selected | Upside | |
| a | |||
| DCF (Growth 5y) | 111.32 - 271.68 | 161.60 | 332.8% |
| DCF (Growth 10y) | 141.03 - 315.71 | 196.31 | 425.7% |
| DCF (EBITDA 5y) | 87.65 - 142.29 | 111.31 | 198.1% |
| DCF (EBITDA 10y) | 119.84 - 188.97 | 149.32 | 299.9% |
| Fair Value | 97.53 - 97.53 | 97.53 | 161.19% |
| P/E | 55.71 - 78.01 | 65.58 | 75.6% |
| EV/EBITDA | 45.38 - 82.98 | 62.14 | 66.4% |
| EPV | 81.74 - 125.53 | 103.64 | 177.5% |
| DDM - Stable | 26.81 - 66.24 | 46.52 | 24.6% |
| DDM - Multi | 78.25 - 151.45 | 103.32 | 176.7% |
| Market Cap (mil) | 901.76 |
| Beta | 1.43 |
| Outstanding shares (mil) | 24.15 |
| Enterprise Value (mil) | 1,753.41 |
| Market risk premium | 5.10% |
| Cost of Equity | 9.74% |
| Cost of Debt | 7.72% |
| WACC | 8.07% |